Evidence map›Paper›PMID 40137488›Full record

ReviewToxics2025

Occurrence of 5-Hydroxymethylfurfural, Acrylamide, 3-Monochloro-1,2-Propanoldiol and Melamine in Infant Formulas: What Do We Know About These Compounds?

Xóchitl Yanine Méndez-Alvarado, María Magdalena Eréndira González-Tello, Jorge Luis Chávez-Servín, Karina de la Torre-Carbot, Teresa García-Gasca, Diana Beatriz Rangel-Peniche, Roberto Augusto Ferriz-Martínez

Abstract readReview
In one paragraph

Review in Toxics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xóchitl Yanine Méndez-AlvaradoFaculty of Natural Sciences, Juriquilla Campus, Autonomous University of Querétaro, Av. de las Ciencias S/N, Juriquilla, Querétaro 76230, Mexico.
María Magdalena Eréndira González-TelloFaculty of Natural Sciences, Juriquilla Campus, Autonomous University of Querétaro, Av. de las Ciencias S/N, Juriquilla, Querétaro 76230, Mexico.ORCID 0009-0003-1518-5845
Jorge Luis Chávez-ServínFaculty of Natural Sciences, Juriquilla Campus, Autonomous University of Querétaro, Av. de las Ciencias S/N, Juriquilla, Querétaro 76230, Mexico.ORCID 0000-0002-5866-4825
Karina de la Torre-CarbotFaculty of Natural Sciences, Juriquilla Campus, Autonomous University of Querétaro, Av. de las Ciencias S/N, Juriquilla, Querétaro 76230, Mexico.ORCID 0000-0002-6001-7061
Teresa García-GascaFaculty of Natural Sciences, Juriquilla Campus, Autonomous University of Querétaro, Av. de las Ciencias S/N, Juriquilla, Querétaro 76230, Mexico.ORCID 0000-0002-8793-9963
Diana Beatriz Rangel-PenicheFaculty of Natural Sciences, Juriquilla Campus, Autonomous University of Querétaro, Av. de las Ciencias S/N, Juriquilla, Querétaro 76230, Mexico.
Roberto Augusto Ferriz-MartínezFaculty of Natural Sciences, Juriquilla Campus, Autonomous University of Querétaro, Av. de las Ciencias S/N, Juriquilla, Querétaro 76230, Mexico.ORCID 0000-0002-2495-6985

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the manufacture of infant formulas, from raw materials to the final product, the ingredients are subject to high temperatures which favor the formation of undesirable compounds, some of them from the Maillard reaction, such as 5-hydroxymethylfurfural (HMF) and acrylamide, and others from thermal processing, such as the compound 3-monochloro-1,2-propanoldiol (3-MCPD). Finally, there is also a risk that the product may be adulterated with undesirable components such as melamine and cyanuric acid. Due to the vulnerability of infants during the first stage of life, this review answers the main question: How much of these undesirable compounds are present in commercial infant formulas, and what do we know about them? Accordingly, the review is divided into three sections: (1) Maillard reaction products (HMF and acrylamide), (2) products contained in vegetable oils (3-MCPD), and (3) fraudulent and/or adulterant compounds (melamine and cyanuric acid). The objective is to report on the occurrence of HMF, acrylamide, 3-MCPD, melamine, and cyanuric acid in infant formulas in order to support more solid public health policies related to infant feeding. These undesirable compounds represent a risk to infants, possibly contributing to kidney and neurological damage and causing mutations that increase the development of childhood cancer. Therefore, it is necessary to promote breastfeeding and establish stricter controls, with scientific evidence on the effects of HMF, acrylamide, 3-MCPD, melamine, and cyanuric acid in infant formulas to reduce their short- and long-term effects on infants' health.

Indexed as

3-MCPDacrylamidecyanuric acidHMFinfant formulasmelamine

Identifiers

PMID40137488
PMCPMC11946680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.